We are currently importing the latest prescribing data. You may see incomplete data across the site. Please check back in a couple of hours!

8.3.4: Hormone antagonists

Part of chapter 8 Malignant Disease and Immunosuppression, section 8.3 Sex hormones and hormone antagonists in malignant disease

High-level prescribing trends for Hormone antagonists (BNF section 8.3.4) across all GP practices in NHS England for the last five years. You can explore prescribing trends for this section by CCG, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? We can often provide one-off custom extracts from our prescribing data for free. to find out more.


Abiraterone (0803042T0)
Anastrozole (0803041B0)
Bicalutamide (0803042A0)
Buserelin (0803042B0)
Cyproterone Acetate (0803042E0)
Degarelix (0803042R0)
Enzalutamide (0803042U0)
Exemestane (0803041C0)
Flutamide (0803042H0)
Fulvestrant (0803041AA)
Goserelin Acetate (0803042K0)
Histrelin Acetate (0803042Q0)
Lanreotide (0803043P0)
Letrozole (0803041L0)
Leuprorelin Acetate (0803042N0)
Octreotide Acetate (0803043N0)
Pasireotide (0803043Q0)
Tamoxifen Citrate (0803041S0)
Toremifene Citrate (0803041U0)
Triptorelin (Acetate) (0803042P0)
Triptorelin Embonate (0803042S0)